Zingo
Product Images NDC 61388-123

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Zingo (NDC 61388-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Powder Pharmaceutical Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Carton Label)

Packaging label for Zingo 0.5 mg powder intradermal injection system containing lidocaine hydrochloride monohydrate. The label displays the proprietary name Zingo, the active ingredient and strength, and an illustration of the injection system. The label states it contains 12 sterile units and is manufactured by Powder Pharmaceutical Incorporated, Hong Kong, China. Includes barcode, storage instructions, and other regulatory information.*

FDA Label Image

Device Label (Device Label)

Label for Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system, 0.5 mg, produced by Powder Pharmaceuticals, Inc. The label includes usage instructions, storage conditions, and a barcode, specifying that the product is for single use and prescription only.*

FDA Label Image

Structure Formula (Figure Lhm Structure)

Chemical structure of the active ingredient showing a substituted aromatic amide linked to a diethylamino ethyl group with hydrochloride and hydrate components, associated with the product Zingo from Powder Pharmaceutical Incorporated.*

FDA Label Image

Figure 1a (Figure1a)

An instructional diagram showing hands tearing open a package at a designated notch. The illustration highlights the action needed to open the product packaging, with emphasis on the tear notch for proper opening.*

FDA Label Image

Figure 1b (Figure1b)

An instructional line drawing showing a hand holding a pen-like medical device labeled with 'Start Button' near the top and 'Outlet' at the bottom, illustrating where to press and the device opening.*

FDA Label Image

Figure (Figure2)

An instructional illustration showing a hand holding a Zingo injection device pressed against the forearm of another arm, demonstrating the administration of the product via a subcutaneous injection.*

FDA Label Image

Figure 3 (Figure3)

An illustration showing two hands administering an injection using an auto-injector device into the skin of a person's arm. One hand presses the device firmly against the skin while the other hand activates the injector. The device is cylindrical with a rounded tip.*

FDA Label Image

Figure 4 (Figure4)

An instructional illustration showing a hand holding an injection device pressing it against the forearm of the opposite arm. The illustration includes a label pointing to the device's tip with the instruction 'Avoid gaps.' This image appears to demonstrate the proper use of the injection device for administering Zingo.*

FDA Label Image

Figure 5a (Figure5a)

An instructional illustration showing a hand holding an injector pen device vertically against the forearm. The image includes an arrow pointing to the device tip and the text "Seal outlet against skin," indicating proper placement for injection or administration.*

FDA Label Image

Figure 5b (Figure5b)

An instructional illustration showing three stages labeled A, B, and C for using the Zingo device by Powder Pharmaceutical Incorporated. It depicts the safety configuration with the button locked (A), pressing down against the skin raising the button to an unlocked position ready to press (B), and the button ready to press inward with the thumb (C). Each stage includes arrows demonstrating the pressing actions on the device held against the skin.*

FDA Label Image

Figure 6 (Figure6)

An instructional illustration showing a hand holding a medical injector device labeled 'Zingo.' The image demonstrates pressing the button inward while the injector tip is placed on the skin of a forearm, indicated by arrows and text instructions.*

FDA Label Image

Table 1 (Table1)

A data table titled 'Visual Analogue Scale Score (Full Safety/Efficacy Population)' comparing Adult Study results between Active (N=345) and Placebo (N=348) groups. The table includes adjusted mean least squares means (LSM), difference in LSMs with standard error, and 95% confidence limits for both groups.*

FDA Label Image

Table 2 (Table2)

Data table titled 'Modified FACES Scale Score (ITT Population), Studies 1 and 2' showing mean scores for Active and Placebo groups in two studies, along with difference in least squares means (LSM) and 95% confidence limits. The table includes notes on least squares mean and standard error.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.